Clinical trial backs Irish therapy for chronic runny nose

• Published date: 21 March 2023

The trial run by Galway-based Neurent Medical of its Neuromark device, which was approved for limited market release in the United States in February, showed no serious adverse events in any of the 36 participants

The device precisely applies low power radio frequency energy to hyperactive nerves in the nose to halt the inflammatory response that leads to rhinitis, or chronic runny nose. It is estimated that one in four Americans suffers from the condition.

"People living with chronic rhinitis have had limited options when traditional therapies fail, said Douglas Reh, who is the principal investigator in the clinical trial. "The data [from the trial] showed statistically significant and clinically meaningful improvement in symptoms and...